Home / Belgium / Sequana Medical
Sequana Medical
Short position disclosed on April 21, 2026.
0.69% of the capital sold short
1 disclosing funds
1 disclosures on record
BE0974340722 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
May 14Jun 6Jun 29Jul 22Aug 14
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| TWO Sigma Investments, LP | 0.69% | unchanged | April 21, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| April 21, 2026 | TWO Sigma Investments, LP | 0.69% | still open |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Sequana Medical, source FSMA, data as at April 21, 2026, https://www.quivad.com/action/sequana-medical